Cargando…

Phlegmasia Cerulea Dolens: A New Perspective on Management

This is a case of phlegmasia cerulea dolens (PCD) with unexpected but complete resolution of symptoms with short-term administration of heparin products, despite falling into category IIb according to the Rutherford limb ischemia scale, which regularly requires aggressive surgical intervention. We p...

Descripción completa

Detalles Bibliográficos
Autores principales: Sequeira Gross, Harry G, Jimenez, Yomary, Ciobanu, Camelia, Tarekegn, Kidist, Colon Ramos, Ana, Lazar, Jeffrey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8349176/
https://www.ncbi.nlm.nih.gov/pubmed/34373818
http://dx.doi.org/10.7759/cureus.16257
_version_ 1783735511804805120
author Sequeira Gross, Harry G
Jimenez, Yomary
Ciobanu, Camelia
Tarekegn, Kidist
Colon Ramos, Ana
Lazar, Jeffrey
author_facet Sequeira Gross, Harry G
Jimenez, Yomary
Ciobanu, Camelia
Tarekegn, Kidist
Colon Ramos, Ana
Lazar, Jeffrey
author_sort Sequeira Gross, Harry G
collection PubMed
description This is a case of phlegmasia cerulea dolens (PCD) with unexpected but complete resolution of symptoms with short-term administration of heparin products, despite falling into category IIb according to the Rutherford limb ischemia scale, which regularly requires aggressive surgical intervention. We present a case of a 58-year-old Hispanic female with a past medical history of gastritis who arrived at the emergency room (ER) with acute onset severe pain on the left leg associated with discoloration of the leg. The patient was quickly diagnosed with PCD affecting the left lower extremity, which quickly resolved after administration of heparin infusion for one hour, despite the degree of limb ischemia. There is no consensus for the treatment of this condition. The most interesting feature of this case is the prompt resolution of symptoms with short-term administration of anticoagulation with total resolution without the need for thrombolysis or thrombectomy. This may suggest that prompt pharmacologic treatment in patients eligible for anticoagulation may successfully restore venous flow negating the need for further intervention.
format Online
Article
Text
id pubmed-8349176
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-83491762021-08-08 Phlegmasia Cerulea Dolens: A New Perspective on Management Sequeira Gross, Harry G Jimenez, Yomary Ciobanu, Camelia Tarekegn, Kidist Colon Ramos, Ana Lazar, Jeffrey Cureus Oncology This is a case of phlegmasia cerulea dolens (PCD) with unexpected but complete resolution of symptoms with short-term administration of heparin products, despite falling into category IIb according to the Rutherford limb ischemia scale, which regularly requires aggressive surgical intervention. We present a case of a 58-year-old Hispanic female with a past medical history of gastritis who arrived at the emergency room (ER) with acute onset severe pain on the left leg associated with discoloration of the leg. The patient was quickly diagnosed with PCD affecting the left lower extremity, which quickly resolved after administration of heparin infusion for one hour, despite the degree of limb ischemia. There is no consensus for the treatment of this condition. The most interesting feature of this case is the prompt resolution of symptoms with short-term administration of anticoagulation with total resolution without the need for thrombolysis or thrombectomy. This may suggest that prompt pharmacologic treatment in patients eligible for anticoagulation may successfully restore venous flow negating the need for further intervention. Cureus 2021-07-08 /pmc/articles/PMC8349176/ /pubmed/34373818 http://dx.doi.org/10.7759/cureus.16257 Text en Copyright © 2021, Sequeira Gross et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Oncology
Sequeira Gross, Harry G
Jimenez, Yomary
Ciobanu, Camelia
Tarekegn, Kidist
Colon Ramos, Ana
Lazar, Jeffrey
Phlegmasia Cerulea Dolens: A New Perspective on Management
title Phlegmasia Cerulea Dolens: A New Perspective on Management
title_full Phlegmasia Cerulea Dolens: A New Perspective on Management
title_fullStr Phlegmasia Cerulea Dolens: A New Perspective on Management
title_full_unstemmed Phlegmasia Cerulea Dolens: A New Perspective on Management
title_short Phlegmasia Cerulea Dolens: A New Perspective on Management
title_sort phlegmasia cerulea dolens: a new perspective on management
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8349176/
https://www.ncbi.nlm.nih.gov/pubmed/34373818
http://dx.doi.org/10.7759/cureus.16257
work_keys_str_mv AT sequeiragrossharryg phlegmasiaceruleadolensanewperspectiveonmanagement
AT jimenezyomary phlegmasiaceruleadolensanewperspectiveonmanagement
AT ciobanucamelia phlegmasiaceruleadolensanewperspectiveonmanagement
AT tarekegnkidist phlegmasiaceruleadolensanewperspectiveonmanagement
AT colonramosana phlegmasiaceruleadolensanewperspectiveonmanagement
AT lazarjeffrey phlegmasiaceruleadolensanewperspectiveonmanagement